Delivery Order SPE2DB25D3306-SPE2DB25FUBTY
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,150.03, is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is for the delivery of a specific pharmaceutical product, ADBRY 300 MG/2 ML AUTOINJECTOR 2ML. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a pharmaceutical product. The contract has a ceiling value of $1,210.78 and a period of performance through May 8, 2025. It is a firm-fixed price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,159.00, is a delivery order that provides the ADBRY 300 MG/2 ML AUTOINJECTOR 2ML pharmaceutical product. It has a performance period through November 1, 2024 and uses a firm fixed price pricing arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,980.96 firm fixed price delivery order covers the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award for $5,364.44 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product "ADBRY 150 MG/ML SYRINGEML" with a completion date of May 23, 2024. The contract is a firm fixed price award with no set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,364.74 firm-fixed-price delivery order contract is for the provision of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This award is under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,947.12 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract is for the supply of the pharmaceutical product ADBRY 150 MG/ML SYRINGEML. The contract has a firm fixed price pricing type and an ultimate completion date of June 4, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to the Department of Defense...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $6,332.74, is a delivery order for the medical product ADBRY 150 MG/ML SYRINGEML. It is a firm fixed price contract with a period of performance through February 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $5,617.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 150 MG/ML syringes and has an ultimate completion date of August 7, 2023. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...